Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BND-35 |
Trade Name | |
Synonyms | BND35|BND 35 |
Drug Descriptions |
BND-35 is an antibody targeting ILT3 (LILRB4), which potentially induces antitumor immune activity (Cancer Res (2024) 84 (6_Supplement): 3920). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C207814 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BND-35 | BND-35 | 0 | 1 |
BND-35 + Cetuximab | BND-35 Cetuximab | 0 | 1 |
BND-35 + Nivolumab | BND-35 Nivolumab | 0 | 1 |